- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: ADP receptor inhibitors
Total 76427 results
-
BeiGeneCompletedAdvanced or Inoperable Gastric CancerUnited States, Hungary, Spain, China, Hong Kong, Japan, Australia, Taiwan, Belgium, Czechia, Singapore, France, Poland, United Kingdom, Romania, Russian Federation, Georgia
-
David Liebner, MDWithdrawnLocally Advanced Leiomyosarcoma | Metastatic Leiomyosarcoma | Unresectable Leiomyosarcoma | Stage III Retroperitoneal Sarcoma AJCC v8 | Stage IIIA Retroperitoneal Sarcoma AJCC v8 | Stage IIIB Retroperitoneal Sarcoma AJCC v8 | Stage IV Retroperitoneal Sarcoma AJCC v8United States
-
Massachusetts General HospitalTesaro, Inc.CompletedPancreatic Cancer | Metastatic Pancreatic CancerUnited States
-
zr Pharma & GmbHCompletedNeoplasmsUnited Kingdom, Poland, Slovakia
-
University of Kansas Medical CenterTesaro, Inc.Active, not recruitingPancreatic CancerUnited States
-
Zai Lab (Shanghai) Co., Ltd.Completed
-
PfizerMedivation, Inc.CompletedAdvanced Solid TumorsUnited States
-
Massachusetts General HospitalTesaro, Inc.RecruitingLung CancerUnited States
-
University Health Network, TorontoAstraZenecaCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI); BeiGeneCompletedRecurrent Glioblastoma | Recurrent WHO Grade III Glioma | Recurrent WHO Grade II Glioma | IDH1 Mutation | IDH2 MutationUnited States
-
UNICANCERARCAGY/ GINECO GROUP; SOLTI Breast Cancer Research GroupActive, not recruitingER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer | a Germline or Somatic BRCA Mutation, or a Deleterious Alteration of Other Genes Involved in Homologous Recombination Repair (HRR) or in MSI StatusFrance
-
AstraZenecaKuDOS Pharmaceuticals LimitedCompletedMelanoma NeoplasmsUnited States, United Kingdom
-
Ibrahim Halil SahinGlaxoSmithKlineNot yet recruitingMMR-D/MSI-H Colorectal CancersUnited States
-
Sun Yat-sen UniversityJiangsu Hengrui Pharmaceutical Co., Ltd.Recruiting
-
H. Lee Moffitt Cancer Center and Research InstituteGlaxoSmithKlineRecruitingPenile CarcinomaUnited States
-
VA Office of Research and DevelopmentRecruitingMetastatic Castrate Resistant Prostate Cancer | BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2 | RAD51B, RAD51C, RAD51D, or RAD54L MutationsUnited States
-
Tesaro, Inc.Completed
-
Brown UniversityBayer; The Miriam Hospital; Rhode Island Hospital; Clovis Oncology, Inc.Active, not recruitingMetastatic Castration-resistant Prostate CancerUnited States
-
AstraZenecaCompletedAdvanced Solid TumorsUnited States, Spain
-
The Netherlands Cancer InstituteAstraZenecaActive, not recruitingHead and Neck Neoplasms | Carcinoma, Squamous Cell | Laryngeal Cancer Stage II | Laryngeal Cancer Stage IIINetherlands
-
zr Pharma & GmbHCompletedAdvanced Solid TumorsUnited Kingdom
-
University of Alabama at BirminghamWithdrawnOvarian Cancer RecurrentUnited States
-
Geoffrey Shapiro, MD, PhDEli Lilly and Company; AstraZenecaCompletedSolid TumorUnited States
-
PfizerMedivation, Inc.CompletedAdvanced Solid TumorsUnited States, Canada
-
National Cancer Institute (NCI)Terminated
-
Ruijin HospitalUnknownStomach Cancer | Gastric CancerChina
-
AstraZenecaCompletedSolid TumoursBelgium, France, Netherlands, United Kingdom, Denmark
-
Haider MahdiGlaxoSmithKline; Zenith EpigeneticsRecruitingOvarian Cancer | Recurrent Solid TumorsUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruiting
-
Xiaoxiang ChenRecruitingNeoplasms | Neoplasms by Histologic Type | Urogenital Neoplasms | Neoplasms by Site | Carcinoma | Neoplasms, Glandular and Epithelial | Genital Neoplasms, Female | Ovarian Diseases | Adnexal Diseases | Carcinoma, Ovarian Epithelial | Ovarian Cancer | Angiogenesis | Genital Diseases, Female | Antineoplastic Agents | BRCA1... and other conditionsChina
-
University of PennsylvaniaAstraZeneca; Myriad Genetics, Inc.RecruitingHigh Grade Serous CarcinomaUnited States
-
AstraZenecaActive, not recruitingRelapsed Ovarian Cancer | Following Complete or Partial Response to Platinum Based Chemotherapy | Platinum SensitiveChina, Malaysia
-
Peter MacCallum Cancer Centre, AustraliaSuspendedPidnarulex and Talazoparib in Patients With Metastatic Castration Resistant Prostate Cancer (REPAIR)Metastatic Castration Resistant Prostate Cancer (mCRPC)Australia
-
Tesaro, Inc.European Network of Gynaecological Oncological Trial Groups (ENGOT); US Oncology... and other collaboratorsCompletedA Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian CancerOvarian Neoplasms | Platinum Sensitive Ovarian CancerUnited States, Belgium, Sweden, Germany, Israel, Austria, Canada, Denmark, Spain, Italy, United Kingdom, Poland, France, Hungary, Norway
-
Melinda TelliPfizer; BioMarin PharmaceuticalCompletedAdvanced Breast Cancer | HER2/Neu Negative | Triple-Negative Breast CancerUnited States
-
Zai Lab (Shanghai) Co., Ltd.TerminatedGastric Cancer | Triple Negative Breast Cancer | Endometrial Carcinoma | Biliary Tract CarcinomaChina
-
Tesaro, Inc.CompletedNeoplasms | Ovarian Neoplasms | Solid Tumor | Hepatic ImpairmentUnited States
-
PfizerMedivation, Inc.Completed
-
PfizerMedivation, Inc.; Myriad Genetic Laboratories, Inc.TerminatedBreast Neoplasms | BRCA 1 Gene Mutation | BRCA 2 Gene MutationUnited States, Spain, United Kingdom, Germany, France
-
The Netherlands Cancer InstituteCompletedBreast Cancer | Ovarian Cancer | Advanced CancerNetherlands
-
Lisette NixonAstraZenecaUnknownNon-small Cell Lung CancerUnited Kingdom
-
University of Michigan Rogel Cancer CenterCompletedBreast CancerUnited States
-
GlaxoSmithKlineCompletedInfluenza, Human
-
SanofiUNC Lineberger Comprehensive Cancer CenterCompletedBrain Metastases | Estrogen Receptor Negative (ER-Negative) Breast Cancer | Progesterone Receptor Negative (PR-Negative) Breast Cancer | Human Epidermal Growth Factor Receptor 2 Negative (HER2-Negative) Breast CancerUnited States
-
Otsuka Pharmaceutical Development & Commercialization...Otsuka America PharmaceuticalCompletedMajor Depressive DisorderUnited States
-
The Clatterbridge Cancer Centre NHS Foundation...University of LiverpoolUnknownCervical CancerUnited Kingdom
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...RecruitingNeoadjuvant Therapy | High Risk Prostate Cancer | Locally Advanced Prostate Cancer | Intense Endocrine TherapyChina
-
AdaptimmuneGOG FoundationRecruitingOvarian CancerUnited States, Spain, France, Canada, United Kingdom
-
National Cancer Center Hospital EastMerck Sharp & Dohme LLCCompleted
-
Memorial Sloan Kettering Cancer CenterBristol-Myers Squibb; Clovis Oncology, Inc.Active, not recruiting